Effect of Treatment with Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients with End-Stage Renal Disease Awaiting Transplantation
M. A. Mujtaba, W. J. Komocsar, E. Nantz, M. D. Samaniego, S. L. Henson, J. A. Hague, A. L. Lobashevsky, N. G. Higgins, M. Czader, B. K. Book, M. D. Anderson, M. D. Pescovitz, T. E. Taber
Dive into the research topics of 'Effect of Treatment with Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients with End-Stage Renal Disease Awaiting Transplantation'. Together they form a unique fingerprint.